A systematic review has assessed the efficacy of Vitamin E in the treatment of Alzheimer’s and for the prevention of progression of mild cognitive impairment (MCI) to dementia.

The authors found no evidence for Vitamin E being of benefit in the treatment of Alheimer’s Disease or MCI. They recommend that future trials assessing Vitamin E treatments for Azheimer’s Disease should not be restricted to alpha-tocopherol.

A full copy of the cochrane review is available at the link below.




November 22, 2012